MBT
VRTX icon

Montecito Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Montecito Bank & Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$508K Buy
1,022
+92
+10% +$40.8K 0.08% 205
2026
Q1 		$415K Sell
930
-297
-24% -$138K 0.07% 212
2025
Q4 		$556K Sell
1,227
-1,012
-45% -$436K 0.09% 189
2025
Q3 		$877K Buy
+2,239
New +$936K 0.14% 151
2025
Q1 		$849K Buy
1,752
+93
+6% +$43.3K 0.15% 149
2024
Q4 		$668K Buy
1,659
+40
+2% +$18.5K 0.12% 173
2024
Q3 		$753K Buy
+1,619
New +$778K 0.13% 158

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

Montecito Bank & Trust's VRTX Position: Q2 2026 in Review

Montecito Bank & Trust increased its Vertex Pharmaceuticals (VRTX) stake by 9.9% in Q2 2026, buying an estimated $40.8K and bringing the position to 1,022 shares worth $508K. The position accounts for 0.08% of the portfolio, ranked #205.

Montecito Bank & Trust first reported a position in VRTX in Q3 2024 and has held it in 7 quarters since. The position peaked at $877K in Q3 2025. 334 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Montecito Bank & Trust held 1,022 shares of Vertex Pharmaceuticals worth $508K as of Q2 2026.
  • Montecito Bank & Trust bought 92 Vertex Pharmaceuticals shares in Q2 2026, an estimated $40.8K.
  • Vertex Pharmaceuticals made up 0.08% of Montecito Bank & Trust's portfolio in Q2 2026, its #205 holding.
  • Montecito Bank & Trust first reported a position in Vertex Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Montecito Bank & Trust's Vertex Pharmaceuticals position peaked at $877K in Q3 2025.
  • 334 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Montecito Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.